Clinical Biospecimen Collection
ConditionCancer Risk
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNorth Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists
About this trial
New York Cancer and Blood Specialists(NYCBS) is dedicated to provide world-class, patient-centered, affordable care to patients with cancer and blood disorders in their own communities, close to family and friends. Our vision is a world free of cancer and blood disorders by contributing to the search for cures by offering cutting-edge clinical trials and personalized, state-of-the-art treatments that save and prolong lives. In support of these objectives NYCBS has created a centralized oncology biorepository in tandem with a longitudinal study to support translational research. This study establishes a biological sample bank and associated data reservoir from thousands of cancer patients, high risk populations, and survivors. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. Researchers will then use these samples and information to better understand how cancer affects the body over time in order to formulate new treatments. The information and samples provided will allow the testing of new therapies and aid in the development of new medical treatments.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Subjects must be at least 18 years of age
Subjects must be deemed competent by a qualified clinical study researcher to provide legally documented informed consent
Subjects may or may not have active disease at the time of enrollment
Biospecimens collected under this protocol may be obtained from subjects with benign conditions, subjects who have been diagnosed with or suspected of having oncological diseases, infectious diseases, auto-immune diseases, endocrine disorders, as well as subjects from healthy normal donors.
Disqualifiers
None
Trial population
Subjects diagnosed with or suspected of having cancerous disease, or from healthy, normal donors with the goal of aiding in biomarker research, early detection of disease, and development of new devices or therapies.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Development of Assays, or Novel Diagnostic's and Treatments to Improve the Quality/Quantity of life for diseased individuals.
Expedite development of diagnostic assays and/or novel treatments to improve the quality and/or quantity of life for diseased individuals. Samples may also be utilized in the development of commercial diagnostic reagents." Reagents such as RNA, DNA, and proteins may be involved. Use of this genetic information may aid in the development of novel diagnostics and therapies for patients with certain diseases.
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists
Lead sponsor
NY Health d/b/a New York Cancer and Blood Specialists
Sponsor institution
Source ClinicalTrials.gov